Lupin Ltd.
BSE: 500257 | Sector: Health care |
NSE: LUPIN | ISIN Code: INE326A01037 |
BSE 00:00 | 27 May | 606.15 |
5.40 (0.90%) |
OPEN
608.00 |
HIGH
608.00 |
LOW
596.55 |
NSE 00:00 | 27 May | 605.75 |
5.25 (0.87%) |
OPEN
605.00 |
HIGH
608.00 |
LOW
596.05 |
OPEN | 608.00 |
PREVIOUS CLOSE | 600.75 |
VOLUME | 59084 |
52-Week high | 1267.50 |
52-Week low | 583.05 |
P/E | |
Mkt Cap.(Rs cr) | 27,553 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Lupin Ltd.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular Diabetology Asthma Pediatric CNS GI Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment....> More
Lupin Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
27,553 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
2 | |
Latest Dividend | (%) | 325.00 | |
Latest Dividend Date | 27 Jul 2021 | ||
Dividend Yield | (%) | 0.66 | |
Book Value / Share | (![]() |
[*S] | 399.30 |
P/B Ratio | (![]() |
[*S] | 1.52 |
News
Lupin Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 3883.03 | 3783.1 | 2.64 |
Other Income | 15.84 | 48.81 | -67.55 |
Total Income | 3898.87 | 3831.91 | 1.75 |
Total Expenses | 3615.21 | 3065.97 | 17.91 |
Operating Profit | 283.66 | 765.94 | -62.97 |
Net Profit | -511.73 | 464.37 | -210.2 |
Equity Capital | 90.9 | 90.74 | - |
Lupin Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Alkem Lab | 3042.05 | 0.59 | 36367.71 |
Aurobindo Pharma | 529.60 | -1.10 | 31029.26 |
Laurus Labs | 566.60 | 1.32 | 30446.25 |
Lupin | 606.15 | 0.90 | 27552.55 |
Glaxosmi. Pharma | 1519.30 | 0.40 | 25738.46 |
Ipca Labs. | 901.85 | -1.67 | 22879.94 |
Syngene Intl. | 531.10 | 0.70 | 21319.95 |
Lupin Ltd - SHAREHOLDING PATTERN
|
|
Lupin Ltd - Research Reports
Lupin Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -5.05% | -5.11% | 1.03% | 0.53% |
1 Month | -20.09% | -20.15% | -4.31% | -4.93% |
3 Month | -18.34% | -18.36% | -1.74% | -1.84% |
6 Month | -33.78% | -33.82% | -3.89% | -3.96% |
1 Year | -49.62% | -49.66% | 7.37% | 6.62% |
3 Year | -18.52% | -18.51% | 38.31% | 37.13% |
Lupin Ltd - STOCK STRENGTH
Today's Low/High | 596.55 | 608.00 | |
Week Low/High | 583.05 | 650.00 | |
Month Low/High | 583.05 | 768.00 | |
YEAR Low/High | 583.05 | 1268.00 | |
All TIME Low/High | 0.80 | 2127.00 |
Quick Links for Lupin:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices